Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Recurrence × CP protocol × 1 year × Clear all

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 5 Ovarian Neoplasms 2 Neoplasm Metastasis 2 Endometrial Neoplasms 2 Uterine Cervical Neoplasms 1 Urologic Neoplasms 1 Urogenital Neoplasms 1 Triple Negative Metastatic Breast Cancer 1 Triple Negative Breast Neoplasms 1 Sarcopenia 1 Penile Neoplasms 1 Non-Small Cell Lung Cancer With HER2- Mutations 1 Non Small Cell Lung Carcinoma NSCLC 1 Neoplasms 1 Malnutrition 1 Male Urogenital Diseases 1 Lung Neoplasms 1 First-line Advanced NSCLC Patients 1 Fallopian Tube Neoplasms 1 Dysgeusia 1 Carcinoma 1 Advanced Solid Tumor 1

Interventions

Cyclophosphamide 37 venetoclax 27 fludarabine 27 Dexamethasone 27 pembrolizumab 20 Rituximab 17 Gemcitabine 16 pomalidomide 15 Cytarabine 14 Lenalidomide 13 Nivolumab 11 fludarabine phosphate 10 carfilzomib 10 Temozolomide 10 Etoposide 10 Calcium Dobesilate 10 Azacitidine 10 Injections 9 obinutuzumab 8 glofitamab 8 daratumumab 8 cemiplimab 7 Cisplatin 7 Capecitabine 7 Bevacizumab 7 zanubrutinib 6 selinexor 6 ruxolitinib 6 ibrutinib 6 Decitabine 6

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡